A detailed history of Jpmorgan Chase & CO transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 38,187 shares of PRME stock, worth $153,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,187
Previous 42,081 9.25%
Holding current value
$153,893
Previous $294,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.3 - $8.03 $16,744 - $31,268
-3,894 Reduced 9.25%
38,187 $196,000
Q1 2024

May 10, 2024

SELL
$6.35 - $9.39 $21,831 - $32,282
-3,438 Reduced 7.55%
42,081 $294,000
Q4 2023

Feb 12, 2024

BUY
$5.59 - $9.55 $103,442 - $176,722
18,505 Added 68.5%
45,519 $403,000
Q3 2023

Nov 14, 2023

SELL
$9.5 - $15.07 $34,751 - $55,126
-3,658 Reduced 11.93%
27,014 $257,000
Q2 2023

Aug 11, 2023

BUY
$11.41 - $17.05 $202,812 - $303,063
17,775 Added 137.82%
30,672 $449,000
Q1 2023

May 18, 2023

BUY
$11.21 - $21.11 $142,815 - $268,941
12,740 Added 8114.65%
12,897 $158,000
Q1 2023

May 11, 2023

SELL
$11.21 - $21.11 $108,927 - $205,125
-9,717 Reduced 98.41%
157 $1,000
Q4 2022

Feb 13, 2023

BUY
$15.2 - $21.12 $150,084 - $208,538
9,874 New
9,874 $184,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $386M
More about PRME
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.